News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biogen Idec, Inc. (Massachusetts) (BIIB) Says Death of MS Patient Not Related to Drug


10/8/2013 7:34:55 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Biogen Idec Inc. BIIB +0.19% said its new multiple-sclerosis drug, Tecfidera, wasn't to blame for the death earlier this year of a 59-year-old woman who had taken the pill. In July, the Weston, Mass., biotech company said it was investigating the death of the woman from a form of pneumonia that the company said was common in multiple-sclerosis patients. She had taken Tecfidera for 5½ weeks before vomiting, diarrhea and other side effects prompted her to stop taking the pill, and died 2½ weeks after discontinuing treatment, the company had said.

Help employers find you! Check out all the jobs and post your resume.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES